Description
Why It’s Done:
The CD79a test is typically used to:
• Diagnose B-cell lymphomas, including types such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma.
• Distinguish B-cell tumors from other types of lymphomas or cancers that might have similar clinical features but originate from different cell types (e.g., T-cell lymphomas).
• Assist in classifying the type of lymphoma or other hematologic malignancies.
• Monitor patients with B-cell malignancies to evaluate treatment effectiveness or disease recurrence.
Preparation:
• No special preparation is required for the test itself, as it is typically done on tissue samples obtained through biopsy or surgery.
• Inform your healthcare provider of any medications or medical conditions that may affect your treatment or the collection of tissue samples.
• The sample collection is typically done by a pathologist or surgeon during a biopsy or surgical procedure.
